CG
SLS icon

Cutler Group’s SELLAS Life Sciences SLS Stock Holding History

Cutler Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-300
Closed – – 4633
2022
Q4 		$0 Sell
300
-1,200
-80% -$3.37K ﹤0.01% 5142
2022
Q3 		$3K Sell
1,500
-500
-25% -$1.38K ﹤0.01% 4031
2022
Q2 		$4K Hold
2,000
– – ﹤0.01% 3919
2022
Q1 		$13K Buy
+2,000
New +$11.7K ﹤0.01% 3414
2021
Q4 		– Sell
-200
Closed -$1K – 6006
2021
Q3 		$1K Sell
200
-6,700
-97% -$62.2K ﹤0.01% 5423
2021
Q2 		$76K Sell
6,900
-10,400
-60% -$101K ﹤0.01% 2121
2021
Q1 		$147K Buy
+17,300
New +$142K 0.01% 1478
2017
Q2 		– Sell
-1
Closed – – 7014
2017
Q1 		$0 Hold
1
– – ﹤0.01% 7135
2016
Q4 		$1K Buy
+1
New +$5.82K ﹤0.01% 6131

Other funds holding SLS

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cutler Group's SLS Position: Q1 2023 in Review

Cutler Group sold out of SELLAS Life Sciences (SLS) in Q1 2023, closing a stake of 300 shares.

Cutler Group first reported a position in SLS in Q4 2016 and held it in 9 quarters. The position peaked at $147K in Q1 2021. 22 funds tracked by Wall St. Rank hold SLS as of Q1 2023.

  • Cutler Group reported no remaining SELLAS Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 300 SELLAS Life Sciences shares in Q1 2023.
  • Cutler Group first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 9 quarters.
  • Cutler Group's SELLAS Life Sciences position peaked at $147K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.